# ICU Medical Inc: Form 10-K for the period ended Dec 31, 2014

- Company: [ICU Medical Inc](/companies/icui.md) (CIK 883984)
- Form: 10-K
- Filed: 2015-02-20
- Accepted by EDGAR: Feb 20, 2015, 17:04 ET
- Period: 2014-12-31
- Accession: 0000883984-15-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/883984/000088398415000005/icui1231201410-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/883984/000088398415000005/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-10-01 to 2014-12-31 | $79.9m | us-gaap:SalesRevenueNet |
| Revenue | 12 months, 2014-01-01 to 2014-12-31 | $309.3m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2014-01-01 to 2014-12-31 | $157.9m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-10-01 to 2014-12-31 | $39.7m | us-gaap:GrossProfit |
| Gross profit | 12 months, 2014-01-01 to 2014-12-31 | $151.4m | us-gaap:GrossProfit |
| Research and development | 12 months, 2014-01-01 to 2014-12-31 | $18.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2014-01-01 to 2014-12-31 | $88.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2014-01-01 to 2014-12-31 | $39.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2014-01-01 to 2014-12-31 | $13.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-10-01 to 2014-12-31 | $7.4m | us-gaap:NetIncomeLoss |
| Net income | 12 months, 2014-01-01 to 2014-12-31 | $26.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.46 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months, 2014-01-01 to 2014-12-31 | $1.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.48 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months, 2014-01-01 to 2014-12-31 | $1.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2014-01-01 to 2014-12-31 | 15,647,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2014-01-01 to 2014-12-31 | $60.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2014-01-01 to 2014-12-31 | $16.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2014-01-01 to 2014-12-31 | $5.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-12-31 | $275.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-12-31 | $437.2m | us-gaap:AssetsCurrent |
| Total assets | at 2014-12-31 | $541.1m | us-gaap:Assets |
| Current liabilities | at 2014-12-31 | $28.7m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2014-12-31 | $508.3m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/883984/000088398415000005/icui1231201410-k.htm

Filed Feb 20, 2015.
Source: SEC EDGAR, the filing index for accession 0000883984-15-000005. Last ingested by Listed: Nov 14, 2026, 20:54 ET. No prices; not investment advice.
